Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers
Clinical trial NCT01344824 · COMPLETED
Trial details
- NCT number
- NCT01344824
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2016-05-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.